Patient case studies
37-year-old Jessica feels that her family is complete and is worried about unintentionally becoming pregnant.*
37-year-old Jessica feels that her family is complete and is worried about unintentionally becoming pregnant.†
Read Jessica's story, and other fictional patient case studies, to find out how NEXPLANON® could address some of the common issues that women may have when starting or switching contraceptive methods.
Read the case studies*Fictional patient
†Fictional patient
NEXPLANON® counselling tips
Are you confident discussing NEXPLANON® with women seeking contraception?
View our tips to support your consultations, including:
- what questions to ask
- how to address bleeding concerns†
- how to address bleeding concerns‡
- information on common side effects
†NEXPLANON® ‡NEXPLANON® use can result in changes to menstrual bleeding patterns that are unpredictable beforehand.1 In clinical trials 22.2% of IMPLANON (etonogestrel implant) users experienced amenorrhoea, 33.6% experienced infrequent bleeding, 6.7% experienced frequent bleeding and 17.7% experienced prolonged bleeding.2
LARC: long-acting reversible contraceptive
References
- NEXPLANON® Summary of Product Characteristics
- Mansour D, Korver T et al. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 2008;13 Suppl 1:13-28
Supporting documentation
Prescribing Information | Summary of Product Characteristics | Patient Information LeafletBy clicking the above links you will leave the Organon website and be taken to external websites.
GB-XPL-11007 | Date of preparation: July 2021
GB-XPL-115009 | Date of preparation: July 2021